Dr. Michael Ament, MD
Neurology (Neurology Physician)
At a glance
- In the NPI registry since
- 2006
Licensed in Colorado since 2002, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CO license 40730 (first issued 2002; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Emgality Pen (galcanezumab-gnlm) Other prescribers in Denver, CO | 89 |
| Nurtec Odt (rimegepant sulfate) Other prescribers in Denver, CO | 42 |
| Diclofenac Sodium Other prescribers in Denver, CO | 25 |
| Duloxetine Hcl Other prescribers in Denver, CO | 20 |
| Qulipta (atogepant) Other prescribers in Denver, CO | 17 |
| Gabapentin Other prescribers in Denver, CO | 15 |
| Meloxicam Other prescribers in Denver, CO | 13 |
| Phenytoin Sodium Extended Other prescribers in Denver, CO | 12 |
| Estradiol Other prescribers in Denver, CO | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 19 payments worth $823 in total to this clinician.
| AbbVie Inc. | $312 |
|---|---|
| Axsome Therapeutics, Inc. | $290 |
| Lundbeck LLC | $143 |
| Pfizer Inc. | $40.41 |
| Teva Pharmaceuticals USA, Inc. | $36.74 |
| Food and Beverage | $823 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.